InvestorsHub Logo
Followers 40
Posts 6068
Boards Moderated 1
Alias Born 06/29/2011

Re: CoolG73 post# 9508

Sunday, 11/24/2019 7:33:58 AM

Sunday, November 24, 2019 7:33:58 AM

Post# of 17447
CoolG, have they given any reason why these races with LN are hard to treat? If so, I don’t know the logic of testing more patients from this group. It’s like saying, we improve the trial location but we are treating hard to treat patients from this new location. If this is the case, I would rather use the p2 protocol.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News